Discovery and Preclinical Milestone Payments
Executive Summary
We survey early stage milestone payments that have been made over the past year to biotech licensors from their pharma collaborators.You may also be interested in...
European Debut For CMR Surgical’s Versius Surgical Robot In Two UK NHS Hospitals
CMR Surgical’s Versius robotic system is now live in the UK NHS, the company announced 20 February.
Teva Emerges From Restructuring Ready To Grow
Despite seeing an 8% drop in global turnover in 2019, an upbeat Teva says the completion of its restructuring plan has positioned the company to increase its turnover through newly-launched products – including biosimilars, brands and new generics – as well as improve its profit margins through manufacturing optimization.
Executives On The Move: Eisai Taps Celgene And Sanofi VPs For Its Team, And Freeline Selects A CEO
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports